AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Week 1 of the AACR Annual Meeting 2021 wrapped up on Thursday. The meeting drew more than 13,500 attendees...
Cancer is the second leading cause of death globally, accounting for nearly 10 million deaths each year. Late-stage diagnosis is a major contributor of cancer-related mortality, as...
With President Joseph R. Biden in the White House, the United States may be poised to make a major...
Immunotherapy has revolutionized cancer treatment over the past decade, providing potentially lifesaving therapies to many patients who otherwise would have limited options. Despite its success...
The Opening Ceremony of AACR Annual Meeting 2021 set the stage for a dynamic forum for presenting and sharing...
This year at the AACR Annual Meeting, the premier cancer meeting in the world, data from clinical trials testing the latest cancer treatments were featured in three...
For a second year in a row, the Global Scholar-in-Training Award (GSITA) program will welcome early-career researchers from around...
Guest post by Keith Hornberger, PhD The AACR-Chemistry in Cancer Research (CICR) Working Group’s mission is to advocate the...
Each year, the American Association for Cancer Research (AACR) holds Early-career Hill Day, an event that connects AACR Associate...
For the second consecutive year, this year’s AACR Annual Meeting will take place in a virtual format. While we...